NTRA
Price
$235.54
Change
+$0.14 (+0.06%)
Updated
Dec 24 closing price
Capitalization
32.85B
68 days until earnings call
Intraday BUY SELL Signals
NXGL
Price
$1.59
Change
+$0.03 (+1.92%)
Updated
Dec 24 closing price
Capitalization
12.95M
94 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NTRA vs NXGL

Header iconNTRA vs NXGL Comparison
Open Charts NTRA vs NXGLBanner chart's image
Natera
Price$235.54
Change+$0.14 (+0.06%)
Volume$468.12K
Capitalization32.85B
NexGel
Price$1.59
Change+$0.03 (+1.92%)
Volume$24.89K
Capitalization12.95M
NTRA vs NXGL Comparison Chart in %
View a ticker or compare two or three
VS
NTRA vs. NXGL commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTRA is a Buy and NXGL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (NTRA: $235.54 vs. NXGL: $1.59)
Brand notoriety: NTRA and NXGL are both not notable
NTRA represents the Medical Specialties, while NXGL is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: NTRA: 32% vs. NXGL: 30%
Market capitalization -- NTRA: $32.85B vs. NXGL: $12.95M
NTRA [@Medical Specialties] is valued at $32.85B. NXGL’s [@Pharmaceuticals: Other] market capitalization is $12.95M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $204.6B to $0. The average market capitalization across the [@Medical Specialties] industry is $12.46B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.61B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTRA’s FA Score shows that 1 FA rating(s) are green whileNXGL’s FA Score has 0 green FA rating(s).

  • NTRA’s FA Score: 1 green, 4 red.
  • NXGL’s FA Score: 0 green, 5 red.
According to our system of comparison, NTRA is a better buy in the long-term than NXGL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTRA’s TA Score shows that 3 TA indicator(s) are bullish while NXGL’s TA Score has 5 bullish TA indicator(s).

  • NTRA’s TA Score: 3 bullish, 4 bearish.
  • NXGL’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, NXGL is a better buy in the short-term than NTRA.

Price Growth

NTRA (@Medical Specialties) experienced а +4.46% price change this week, while NXGL (@Pharmaceuticals: Other) price change was -15.87% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.56%. For the same industry, the average monthly price growth was -2.21%, and the average quarterly price growth was +21.69%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.63%. For the same industry, the average monthly price growth was -0.63%, and the average quarterly price growth was +1.00%.

Reported Earning Dates

NTRA is expected to report earnings on Mar 04, 2026.

NXGL is expected to report earnings on Mar 30, 2026.

Industries' Descriptions

@Medical Specialties (+1.56% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (-0.63% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTRA($32.8B) has a higher market cap than NXGL($12.9M). NTRA YTD gains are higher at: 48.793 vs. NXGL (-64.350). NXGL has higher annual earnings (EBITDA): -2.25M vs. NTRA (-268.34M). NTRA has more cash in the bank: 1.04B vs. NXGL (938K). NXGL has less debt than NTRA: NXGL (3.19M) vs NTRA (199M). NTRA has higher revenues than NXGL: NTRA (2.12B) vs NXGL (11.7M).
NTRANXGLNTRA / NXGL
Capitalization32.8B12.9M254,264%
EBITDA-268.34M-2.25M11,905%
Gain YTD48.793-64.350-76%
P/E RatioN/AN/A-
Revenue2.12B11.7M18,094%
Total Cash1.04B938K111,087%
Total Debt199M3.19M6,234%
FUNDAMENTALS RATINGS
NTRA: Fundamental Ratings
NTRA
OUTLOOK RATING
1..100
82
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
32
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NTRANXGL
RSI
ODDS (%)
Bearish Trend 3 days ago
73%
Bullish Trend 3 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
65%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
Bearish Trend 9 days ago
81%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
89%
Aroon
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
NTRA
Daily Signal:
Gain/Loss:
NXGL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EPC17.440.34
+1.99%
Edgewell Personal Care Company
CNTA25.680.42
+1.66%
Centessa Pharmaceuticals plc
STLA11.030.01
+0.09%
Stellantis NV
BVFL18.13-0.09
-0.49%
BV Financial
SNES2.33-0.02
-0.85%
SenesTech Inc.

NTRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTRA has been loosely correlated with GH. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if NTRA jumps, then GH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTRA
1D Price
Change %
NTRA100%
+0.06%
GH - NTRA
54%
Loosely correlated
-0.12%
ISRG - NTRA
53%
Loosely correlated
-0.03%
VCYT - NTRA
50%
Loosely correlated
-0.35%
TWST - NTRA
49%
Loosely correlated
-0.77%
GKOS - NTRA
47%
Loosely correlated
+0.40%
More

NXGL and

Correlation & Price change

A.I.dvisor tells us that NXGL and NVST have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NXGL and NVST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NXGL
1D Price
Change %
NXGL100%
+1.92%
NVST - NXGL
27%
Poorly correlated
+0.59%
GKOS - NXGL
25%
Poorly correlated
+0.40%
TWST - NXGL
24%
Poorly correlated
-0.77%
ITGR - NXGL
24%
Poorly correlated
+1.21%
NTRA - NXGL
24%
Poorly correlated
+0.06%
More